Found 8 matching trials
An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections to Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM) PHASE2 This study is designed to assess the efficacy, safety and tolerability of i...
Show More Location
Cardiology, P.C. & Center for Therapeutic Angiogenesis
Learn More & Join Trial
Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated Cardiomyopathy PHASE2 This study is designed to assess the safety profile and the efficacy of car...
Show More Location
Minneapolis Heart Institute
Learn More & Join Trial
Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy PHASE1 The purpose of this research is to determine if a subject's own bone marrow...
Show More Location
University of Michigan Center for Oral Health Research
Learn More & Join Trial
Cell Therapy for Craniofacial Bone Defects PHASE1 The purpose of this research is to determine if a patient's own bone marrow...
Show More Location
Michigan Center for Oral Health Research
Learn More & Join Trial
An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI) PHASE3 This study is designed to evaluate the efficacy and safety of ixmyelocel-T,...
Show More Learn More & Join Trial
Use of Ixmyelocel-T (Formerly Cardiac Repair Cell [CRC] Treatment) in Patients With Heart Failure Due to Dilated Cardiomyopathy (IMPACT-DCM) PHASE2 This study is designed to assess the safety and tolerability of Cardiac Rep...
Show More Location
Emory University Hospital Midtown
Learn More & Join Trial
Ixmyelocel-T Treatment of Patients With Osteonecrosis of the Femoral Head PHASE3 The purpose of this study is to determine if Ixmyelocel-T grafting with dem...
Show More Location
Sinai Hospital of Baltimore
Learn More & Join Trial
Use of Ixmyelocel-T (Formerly Vascular Repair Cells [VRC]) in Patients With Peripheral Arterial Disease to Treat Critical Limb Ischemia PHASE2 This study is designed to evaluate the safety and efficacy of autologous Va...
Show More Learn More & Join Trial